We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.59B
AUM Growth
+$202M
Cap. Flow
+$46.2M
Cap. Flow %
1.79%
Top 10 Hldgs %
21.22%
Holding
269
New
22
Increased
94
Reduced
105
Closed
21

Top Buys

Rank Stock Value
1
FULT icon
Fulton Financial
FULT
+$16.2M
2
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$15.7M
3
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$14.5M
4
TTMI icon
TTM Technologies
TTMI
+$14.5M
5
VITL icon
Vital Farms
VITL
+$12.9M

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$26.6M
2
FTAI icon
FTAI Aviation
FTAI
+$22.8M
3
CRS icon
Carpenter Technology
CRS
+$19.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$17.8M
5
VAL icon
Valaris
VAL
+$16.7M

Sector Composition

Rank Sector Weight
1 Technology 24.96%
2 Healthcare 24.88%
3 Industrials 21.18%
4 Financials 12%
5 Consumer Discretionary 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.88B
$31.7M 1.22%
569,798
+83,116
+17% +$4.23M
GTLS icon
27
Chart Industries
GTLS
$31.4M 1.21%
252,661
+9,181
+4% +$1.21M
MMSI icon
28
Merit Medical Systems
MMSI
$4.41B
$31.1M 1.2%
315,179
-43,974
-12% -$4.02M
MC icon
29
Moelis & Co
MC
$5.02B
$30.2M 1.17%
440,330
+5,844
+1% +$377K
PDFS icon
30
PDF Solutions
PDFS
$2.14B
$28.4M 1.1%
895,248
+19,673
+2% +$639K
BBIO icon
31
BridgeBio Pharma
BBIO
$15.9B
$28.1M 1.09%
1,103,508
+437,164
+66% +$11.5M
FORM icon
32
FormFactor
FORM
$8.23B
$27.8M 1.08%
604,724
+56,316
+10% +$2.81M
TVTX icon
33
Travere Therapeutics
TVTX
$5.27B
$27.4M 1.06%
1,960,659
+323,513
+20% +$3.37M
NVEE
34
DELISTED
NV5 Global
NVEE
$26.2M 1.01%
1,122,664
+34,880
+3% +$829K
AGYS icon
35
Agilysys
AGYS
$3B
$26.1M 1.01%
239,455
-886
-0.4% -$94.8K
IDCC icon
36
InterDigital
IDCC
$6.73B
$25.6M 0.99%
180,987
+60,575
+50% +$7.94M
OLLI icon
37
Ollie's Bargain Outlet
OLLI
$4.02B
$25M 0.97%
257,297
+37,893
+17% +$3.65M
NEO icon
38
NeoGenomics
NEO
$1.9B
$24.8M 0.96%
1,682,214
-162,401
-9% -$2.54M
VITL icon
39
Vital Farms
VITL
$581M
$24.8M 0.96%
706,440
+364,837
+107% +$12.9M
TNET icon
40
TriNet
TNET
$2.74B
$24.5M 0.95%
252,819
+2,651
+1% +$264K
LITE icon
41
Lumentum
LITE
$57B
$24M 0.93%
378,535
+85,353
+29% +$4.62M
RXO icon
42
RXO
RXO
$4.83B
$23.9M 0.92%
852,441
+409,055
+92% +$11.6M
FULT icon
43
Fulton Financial
FULT
$4.74B
$23.7M 0.92%
1,307,559
+890,630
+214% +$16.2M
RMBS icon
44
Rambus
RMBS
$11B
$23.7M 0.92%
561,414
+166,453
+42% +$8.07M
TMDX icon
45
Transmedics
TMDX
$2.56B
$23.7M 0.92%
150,907
-172,443
-53% -$26.6M
WVE icon
46
Wave Life Sciences
WVE
$1.12B
$23.6M 0.91%
2,881,510
+388,280
+16% +$2.32M
FA icon
47
First Advantage
FA
$3.83B
$23.5M 0.91%
1,183,050
+24,217
+2% +$432K
LBPH
48
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$22.8M 0.88%
683,642
+455,119
+199% +$15.7M
FN icon
49
Fabrinet
FN
$17.1B
$22M 0.85%
93,167
+43,359
+87% +$10M
NOG icon
50
Northern Oil and Gas
NOG
$2.31B
$21.7M 0.84%
611,509
+44,510
+8% +$1.7M
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Emerald Advisers held 269 positions worth $2.59B, up 8.5% from $2.38B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q3 2024 filing shows 22 new, 94 increased, 105 reduced and 21 closed positions. Its largest new stake was Avid Bioservices, Inc. Common Stock: 1,448,916 shares worth $16.5M. The largest sale was Transmedics, an estimated $26.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q3 2024 buy was Avid Bioservices, Inc. Common Stock: 1,448,916 shares worth $16.5M.
  • Emerald Advisers added most to Fulton Financial in Q3 2024, an estimated $16.2M increase.
  • Emerald Advisers's biggest Q3 2024 reduction was Transmedics, cutting an estimated $26.6M.
  • Emerald Advisers fully exited Savers in Q3 2024, selling an estimated $9.16M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.59B portfolio in Q3 2024.
  • Emerald Advisers opened 22 new positions and closed 21 in Q3 2024.
  • Emerald Advisers's portfolio value rose 8.5% quarter-over-quarter to $2.59B.

Based on Emerald Advisers's 13F filing for Q3 2024, filed 29 Oct 2024.